These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29606403)

  • 21. Cancer incidence attributable to tobacco smoking in GCC countries in 2018.
    Al-Zalabani AH
    Tob Induc Dis; 2020; 18():18. PubMed ID: 32256282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avoidable cancers in the Nordic countries. Aims and background.
    Olsen JH
    APMIS Suppl; 1997; 76():1-8. PubMed ID: 9462817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Attributable to Tobacco Smoking in Member Countries of Association of Southeast Asian Nations (ASEAN) in Year 2018.
    Kristina SA; Permitasari NPAL; Krisnadewi KI; Santoso KA; Puspawati PR; Masrida WO; Andriani Y
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):2909-2915. PubMed ID: 31653134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of tobacco control policies implementation on future lung cancer incidence in Europe: An international, population-based modeling study.
    Gredner T; Mons U; Niedermaier T; Brenner H; Soerjomataram I
    Lancet Reg Health Eur; 2021 May; 4():100074. PubMed ID: 34029359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple method to estimate tobacco-related lung cancer deaths based on smoking prevalence data.
    Winkler V; Gbangou A; Kouyate B; Becher H
    Methods Inf Med; 2006; 45(4):397-403. PubMed ID: 16964355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobacco-related cancers in Europe: The scale of the epidemic in 2018.
    Kulhánová I; Forman D; Vignat J; Espina C; Brenner H; Storm HH; Bauld L; Soerjomataram I
    Eur J Cancer; 2020 Nov; 139():27-36. PubMed ID: 32957011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of cancer mortality in the Nordic countries in 2005: effects of various interventions.
    Wiklund K; Hakulinen T; Sparén P
    Eur J Cancer Prev; 1992 Apr; 1(3):247-58. PubMed ID: 1467770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occupational Risk for Oral Cancer in Nordic Countries.
    Tarvainen L; Suojanen J; Kyyronen P; Lindqvist C; Martinsen JI; Kjaerheim K; Lynge E; Sparen P; Tryggvadottir L; Weiderpass E; Pukkala E
    Anticancer Res; 2017 Jun; 37(6):3221-3228. PubMed ID: 28551668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the implications of reducing smoking prevalence: the public health and economic benefits of achieving a 'tobacco-free' UK.
    Hunt D; Knuchel-Takano A; Jaccard A; Bhimjiyani A; Retat L; Selvarajah C; Brown K; Webber LL; Brown M
    Tob Control; 2018 Mar; 27(2):129-135. PubMed ID: 28495977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of changing the prevalence of smoking, alcohol consumption and overweight/obesity on cancer incidence in China from 2021 to 2050: a simulation modelling study.
    Song S; Lei L; Liu H; Yang F; Li N; Chen W; Peng J; Ren J
    EClinicalMedicine; 2023 Sep; 63():102163. PubMed ID: 37662518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Consumption of tobacco in Denmark in the period 1920-1975].
    Nielsen PE; Krarup NB
    Ugeskr Laeger; 1976 Oct; 138(41):2511-6. PubMed ID: 987630
    [No Abstract]   [Full Text] [Related]  

  • 33. Tobacco smoking, cancer and social class.
    Stellman SD; Resnicow K
    IARC Sci Publ; 1997; (138):229-50. PubMed ID: 9353667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis.
    Basu S; Stuckler D; Bitton A; Glantz SA
    BMJ; 2011 Oct; 343():d5506. PubMed ID: 21972295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
    Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
    Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of screening in the Nordic cancer control up to the year 2017.
    Hakama M; Hristova L
    Acta Oncol; 1997; 36(2):119-28. PubMed ID: 9140427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix.
    Storm HH; Kejs AM; Engholm G; Tryggvadóttir L; Klint A; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):713-24. PubMed ID: 20491527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries.
    Ylönen O; Jyrkkiö S; Pukkala E; Syvänen K; Boström PJ
    BJU Int; 2018 Sep; 122(3):384-393. PubMed ID: 29460991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015.
    Kiadaliri AA; Uhlig T; Englund M
    Scand J Rheumatol; 2018 Sep; 47(5):410-417. PubMed ID: 29376465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Cigarette Smoking, Access, and Purchases from Retail Outlets Among Students Aged 13-15 Years - Global Youth Tobacco Survey, 45 Countries, 2013 and 2014.
    D'Angelo D; Ahluwalia IB; Pun E; Yin S; Palipudi K; Mbulo L
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(34):898-901. PubMed ID: 27584595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.